American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(63), 2019
DOI: 10.1128/aac.01671-18
Full text: Unavailable
Minocycline is currently approved in the United States for the treatment of infections caused by susceptible isolates of Acinetobacter spp. The objective of these studies was to determine the minocycline exposures associated with an antibacterial effect against Acinetobacter baumannii in a rat pneumonia model.